This is not the most recent version of the article. View current version (19 SEP 2014)

Intervention Protocol

Tricyclic antidepressants for ADHD in children and adolescents

  1. John Otasowie1,*,
  2. Umunoibalo Ehimare2,
  3. Nevyne Chalhoub1,
  4. Varaidzo Mayowe3

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 23 JAN 2008

DOI: 10.1002/14651858.CD006997


How to Cite

Otasowie J, Ehimare U, Chalhoub N, Mayowe V. Tricyclic antidepressants for ADHD in children and adolescents (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD006997. DOI: 10.1002/14651858.CD006997.

Author Information

  1. 1

    Sheffield Children's NHS Foundation Trust, Child and Adolescent Psychiatry, Sheffield, South Yorkshire, UK

  2. 2

    University of Missouri-Columbia, Department of Psychiatry, Columbia, Missouri, USA

  3. 3

    Sheffield Children's NHS Trust, Research and Development Office, Sheffield, UK

*John Otasowie, Child and Adolescent Psychiatry, Sheffield Children's NHS Foundation Trust, Centenary House, 55 Albert Terrace Road, Sheffield, South Yorkshire, S6 3BR, UK. aiwuyo@yahoo.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 JAN 2008

SEARCH

This is not the most recent version of the article. View current version (19 SEP 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy of tricyclic antidepressants (TCAs) in the reduction of ADHD symptoms within the broad categories of hyperactivity, impulsivity, and/or inattentiveness in young people aged 6-18 years with established diagnoses of ADHD.